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Background: Transcription factors bind to response elements on the promoter regions of genes to regulate
transcriptional activity. One of the major problems with identifying transcription factors is their low abundance
relative to other proteins in the cell. Developing a purification technique specific for transcription factors is crucial
to the understanding of gene regulation. Promoter trapping is a method developed that uses the promoter regions
as bait to trap proteins of interest and then purified using column chromatography. Here we utilize this technique
to study the telomerase promoter, which has increased transcriptional activity in cancer cells. Gaining insight on
how to control the enzyme at the promoter level may give new routes towards cancer treatments.
Results: Our findings show that the telomerase promoter (−170 - +91) and Promoter Trapping isolate a transcriptionally
active and reproducible complex, when analyzed by liquid chromatography tandem mass spectrometry. We were also
able to identify transcription factors, including AP-2 and SP1 known to bind this promoter, as well as show that these two
proteins can bind to each other’s response element.
Conclusion: Here we focus on verifying the ability and versatility of Promoter Trapping coupled with additional
well-characterized methods to identify already known factors responsible for telomerase transcriptional regulation.
Keywords: Mass spectrometry, Transcription factor, Chromatography, Proteomics, PurificationBackground
In most human somatic cells, human telomerase reverse
transcriptase (hTERT) activity is silenced or present at
very low levels whereas cancer cells, germ line cells, and
embryonic stem cells have elevated hTERT activity [1,2].
hTERT is an enzyme that adds repeats of a guanine rich
sequence, called telomeres, to the ends of chromatids
[3,4]. Telomeres are DNA-protein complexes that shield
the ends of chromosomes from degradation and fusion
by creating a protective cap [5]. At birth telomeres are
approximately 15 kb long and after 50 to 70 cell divi-
sions the telomeres undergoes a progressive shortening,
making them too short for replication leading to cell
senescence and eventually death [5,6]. However, it has
been found that in 90% of malignant cells hTERT activity
is increased causing the cell’s telomeres to regenerate* Correspondence: Harry.Jarrett@utsa.edu
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unless otherwise stated.and the cells become immortal [7]. The transcriptional
regulation of hTERT is the subject of a recent review [8].
There are several transcription factor (TF) binding
sites on the hTERT promoter, shown in Figure 1. For ex-
ample, specificity protein (SP1), Enhancer Box (E-Box)
binding TFs and activator protein 2 (AP-2) are all TFs
known to bind the hTERT promoter. Sp1, a C2H2-type
zinc-finger protein that binds to GC-rich motifs, con-
tains five binding sites within the promoter sequence
and has been found to stimulate or suppress transcrip-
tion depending upon its post-translational modifications.
AP-2 binds to the GCCNNNGGC consensus sequence
and has been found to have seven binding sites on the
hTERT promoter. Many of the SP1 and AP-2 binding
sites overlap and we show here a strong influence on
each other.
Transcription of hTERT is regulated by TFs, which ac-
tivate or repress expression. Despite the importance of
the hTERT gene on cell growth, longevity, and tumor
formation, little is known about how it is regulated atLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Promoter trapping with the hTERT promoter yields a transcriptionally active complex. A. Nucleotide sequence of the hTERT
gene regulatory region. Features of known binding regions are noted, such as two E-Boxes, AP2, and SP1 sites. The translational start site (INR),
nucleotide +1, is denoted by the bold arrow. B. Full hTERT promoter containing single stranded (GT)5 tails complexed with TF from HEK293 NE.
hTERT specific TF are purified by annealing (GT)5 tails to a (CA)5-Sepharose column and eluted with a high salt buffer. C. Transcription Assay of
hTERT Promoter Trap Elute. After RNA was transcribed by the promoter trapping eluate, 0.1 pmol 32P-labeled oligo (5′-cggagcgcgcggcatcgcgg-3′)
was extended with reverse transcriptase and analyzed on a 6% polyacrylamide gel containing 8 M urea. Visualization was accomplished with
autoradiography. (+) Indicates the use of rNTP and (−) denotes where rNTP was not used during transcription, as a negative control. The expected
product is 100 base pairs.
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eral potential TFs, however, experimental verification is
often lacking. Most promoter analysis has consisted of
the identification of a single TF bound to this promoter,
at a given time, and under given conditions. These ex-
periments are laborious and fail to identify the complete
set of TFs bound to a particular promoter. A method,
called Promoter Trapping [9], has been developed where
the promoter is “tailed” with single stranded (GT)5. The
DNA-protein complex is allowed to form in solution.
The promoter is then annealed to (CA)5-Sepharose and
any irrelevant proteins can be washed away and the
bound proteins eluted.
Previously, we had developed promoter trapping using
the c-jun promoter, which has very high promoter activ-
ity in reporter assays. Here, promoter trapping [9] was
performed using nuclear extract (NE) from the HEK293
cell line using the hTERT promoter. An overview of the
workflow can be seen in Figure 1. Reporter assays show
this promoter to be 4500-fold less active than the c-jun
promoter and yet promoter trapping results in a tran-
scriptionally active transcription complex. The complex
was characterized by Western and Southwestern blotsand using LC-MS/MS. This characterization of the com-
plex reveals it to be very reproducible and to contain
not only many of the proteins of the RNA polymerase 2
general transcription machinery but also specific tran-
scription factors (SP1, AP2, and USF2) known to bind
this promoter. Thus, promoter trapping is a highly re-
producible method that can be applied to promoters
over a wide-range of promoter strengths.
Results and conclusion
Promoter trapping (PT) is a method that utilizes DNA
response elements present in a gene’s promoter region
(100–1000 base pairs) to enrich for factors responsible
for gene regulation. This method has been used to suc-
cessfully purify the transcription complex bound to the
c-jun promoter [9]. To extend this method to other pro-
moters, we applied this technique in the purification of
hTERT-specific TFs as well as general components of
transcription by using the hTERT core promoter.
Figure 1 depicts the PT method along with the core
promoter sequence used and some of its known binding
sites. To demonstrate the validity of this method and its
ability to purify TFs from any promoter we focus on
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does this method enrich for specific low abundant proteins
but also it is able to capture a functional transcription
complex, which was confirmed with a transcription assay
(Figure 1C). Here, the promoter was transcribed to RNA,
isolated, and then reverse transcribed using specific primer
oligonucleotides. In order for transcription to occur a num-
ber of factors must be present, one being rNTPs. Thus, by
the removal of rNTPs confirms that any bands visualized
from the assay are exclusive to transcription. PT eluate with
rNTP (+) and PT eluate without rNTP (−) were assessed
side by side and as expected the (+) lane produced a well-
defined band of the expected size demonstrating that the
active transcription complex was isolated following pro-
moter trapping while the (−) was blank. An additional
negative control was utilized which included the reaction
mixture minus hTERT promoter DNA, and also produced
a null result (data not shown).
The promoter complex’s activity in vivo is shown with
a reporter assay in Figure 2. The empty vector negative
control shows basal activity, while the hTERT promoter
construct demonstrates a dose-dependent activity. This
experiment was executed next to the c-jun promoter to
show the relative activity. The hTERT promoter has a
lower endogenous activity in HEK293 cells when com-
pared to the c-jun promoter, which gave a 4500-fold
lower signal at the same dose. Thus, even with a much
less active promoter, promoter trapping yields a tran-
scriptionally active complex.
The extent of the purification using the promoter trap-
ping method can be seen in Figure 3A. The first lane
demonstrates the complexity of nuclear extract (NE)
with the multitude of bands present. The flow throughFigure 2 Analysis of hTERT promoter activity using dual luciferase as
transfection, pTK-LUC and hTERT-pMLUC or the empty vector control were
later and acitivity was measured with a dual luciferase assay. Two measurem
was used to measure the activity of each condition. The average of triplica
4579 times higher activity than hTERT.(FT) has a similar pattern with similar intensity as the
NE, indicative of the low abundance of promoter specific
proteins involved in regulating a single promoter. The
washes were also collected (data not shown) and were
equally complex as the NE and FT. The DNA-protein
complex was eluted with 0.5 M NaCl (E), which disrupts
the DNA-protein binding, allowing proteins to elute
while the DNA remains on the column. The eluate dis-
played a much simpler protein mixture, as seen by silver
staining, though it still contained many components, as
seen in Figure 3B. The many components were further
resolved by two-dimensional gel electrophoresis (2DGE)
(Figure 3B) and silver stained for protein visualization.
Although the sample was purified using the PT method,
the eluate is made up of protein-binding proteins and
DNA-binding proteins. While the non-DNA binding
proteins are not TFs they are still significant since they
are involved in transcriptional regulation, however we
will focus on the DNA-binding components. In order to
identify how many proteins are specifically DNA-
binding proteins a two-dimensional southwestern blot
(2DGE-SW) was prepared and probed with 2 nM hTERT
(Figure 3C). Not only does the southwestern blot give
information on the number of DNA-binding proteins in-
volved along with the molecular weights and their re-
spective pI (shown in Figure 3C) but it can also be used
as a tool to study transcriptional regulation [10]. The
comparison of the 2DGE-SW (Figure 3C) to the protein
stained 2DGE (Figure 3B) shows that there are signifi-
cantly less spots in the 2DGE-SW, showing that the
DNA-binding proteins are enriched as well as these
other protein that do not bind DNA. A number of spots
in Figure 3C have physical properties similar to thesay. hTERT was subcloned from hTERT-pUC19 into pMLUC. During
mixed and transfected into cell line HEK293. Cells were lysed 48 hours
ents were taken, renilla and firefly luciferase, and the ratio of the two
tes (from top to bottom) were 1.9, 62733, 13.7, 50, and 160.6. cJun is
Figure 3 Analysis of hTERT TF purification by gel electrophoresis
and Southwestern blotting. (A) Silver stained 1D Gel Electrophoresis
using hTERT promoter trapping. Proteins from the eluate were
separated on a 7.5% SDS polyacrylamide gel. Lanes consist of NE,
flow through (FT), and elute (E). (B) Two-Dimensional PAGE. Eluate
was subjected to 2DGE gel electrophoresis. The first dimension,
isoelectric focusing, was achieved with a 7 cm, pH 3–10 IPG strip. The
second dimension, separation by molecular weight, was done with 12%
sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE).
Visualization was accomplished by silver staining. (C) DNA-Binding by
Two-Dimensional Southwestern Blot. The 2-DE gel shown in Figure 1
was electroblotted onto a PVDF membrane and probed with the 2.0
nM radiolabeled hTERT promoter. Spots indicate the number of high
affinity DNA-binding components of the hTERT complex that were
purified by promoter trapping. In panels B and C, boxes with numbers
show regions of the blot excised for further analysis.
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moter such as specificity protein (SP1, MW = 97 kDa,
pI = 6.9), TATA binding protein (TBP, MW = 38 kDa,
pI = 9.8) and upstream stimulatory factor (USF-2,
MW = 44 kDa, pI ~ 5).
Mass spectrometry is a useful tool for protein charac-
terization and identification especially when combined
with purification techniques such as PT and 2DGE. Gel
plugs believed to represent TFs, based on their physical
properties and bands with a darker appearance in the
2DSW were excised from the 2DGE. The excised pro-
teins were then digested, extracted from the gel plug,
and the peptides were separated on a C-18 column. SP1
and AP2 were confirmed as presented in Figures 4 and
5, respectively. While all identifications are statistically
significant, the sequence coverage of each of the specific
TFs were below our normal benchmark; however, with
MS/MS sequencing producing expected values below
0.005 and the supporting evidence from the Western
(Figure 6) and Southwestern blots (Figure 3C) confirm
the results are significant.
A repressor known to be involved in hTERT regulation
is transcriptional repressor CTCF (TR-CTCF). We were
able to purify and identify TR-CTCF through PT-MS/
MS with 96% probability (data not shown). Other
hTERT specific TF were also found including p53, TGF-
β, as well as proteins from the Mad and STAT families
(data not shown).
While we have discussed hTERT specific factors there
are also general TF that are important to the transcrip-
tional machinery. One of the general TFs with the highest
identification score involved in transcriptional complexes
is General Transcription Factor II-I (GTF2-I) with an ex-
pectation value of 5.9 × 10−05 (shown in Figure 7). GTF2-I
has been known to co-regulate hTERT activity with USF
(Upstream Stimulatory Factor) [11], which was also shown
to be present in the promoter complex (Figure 6) [12].
The higher abundance of general transcription factors fol-
lowing promoter trapping allows isolation and identifica-
tion by mass spectrometry as well as the specific TFs such
as AP2 and SP1.
Western blots were not only used to verify the presence
of TF but also show the extent of TF enrichment by PT
(Figure 6). Whole cell lysate (WCL), nuclear extract (NE),
and the eluate from promoter trapping (PTE) were probed
with five different antibodies to illustrate the enrichment
capabilities of PT. Sp1, USF-2 and TBP are clearly
enriched in the PTE relative to NE. These results are per-
haps not surprising since there are five recognition sites
within the hTERT promoter for Sp1 and two sites that po-
tentially bind USF-2, allowing their enrichment by PT.
RNA Polymerase II (Pol II) had a similar result, although
not as strong of a band as NE; it is reasonable that the nu-
cleus contains excess Pol II. β-actin, an abundant cellular
Figure 4 MS/MS fragmentation of FACPECPK found in SP1_HUMAN. Transcription factor specificity protein 1 (SP1) was identified by LC-MS/
MS and was matched to 504.7168 m/z (2+) by protein database searching with Mascot software utilizing the SwissProt database. SP1 was identified
with a Mascot protein score of 33 and sequence coverage of 5%. The top-ranked tryptic peptide from SP1 contained amino acid FACPECPK, spanning
amino acid residues 686–693 with an expectation value of 0.0056. The italicized amino acids indicate that they are carbamidomethyl modified
cysteines.
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control.
A competitive gel-shift experiment (Figure 8) was
designed using transcription factors known to have interac-
tions with hTERT and canonical binding site oligonucle-
otides. The three frames show gel shifts of radiolabeled
SP1, AP-2, and the E-box oligonucleotides, respectively.
The binding was competed with a 40x excess of unlabeled
oligonucleotides or DNA. When the complete hTERT
promoter DNA is used as the competitor, the shifted
bands are diminished in all experiments showing this con-
tains similar DNA sequences to the canonical oligonucleo-
tides used. To determine if the overlap of SP1 and AP-2
sites shown in Figure 1 has a functional significance, eacholigonucleotide was used for both the gel shift and as a
competitor. Clearly, each oligonucleotide competes with
the other while neither competes for the E-box gel shift.
When 32P-SP1 is competed with the unlabeled AP-2 oligo-
nucleotide or 32P-AP-2 competes with unlabeled SP1, cer-
tain bands are diminished. This suggests that AP-2 and
SP1 not only interacts with hTERT promoter but also
compete with each other’s binding. Evidence of TF inter-
acting with each other within the same promoter has been
previously identified on the PAI-1 gene [13]. This compe-
tition suggests that either transcription factor can bind to
the other’s consensus DNA sequence or there is some
protein-protein interaction between the two. The E-box
gel shift demonstrates a simpler case where there is only
Figure 5 MS/MS fragmentation of peptides corresponding to AP2C_HUMAN and AP2D_HUMAN. Transcription factor activator protein 2
(AP-2) was identified by LC/MSMS and was matched to two different isoforms. AP-2-gamma (AP2C) was identified from m/z = 454.25 (3+) and AP-2-
delta (AP2D) from m/z = 380.23 (2+) by protein database searching with Mascot software utilizing the SwissProt database. AP2C was identified with a
Mascot protein score of 25 and sequence coverage of 3% and 45% probability while AP2D was identified with a Mascot protein score of 33.5 and 4%
sequence coverage and 89% probability. The top-ranked tryptic peptide from AP2D contained amino acid VTIAEVK, spanning amino acid residues
229–235 with an expectation value of 0.002. The top-ranked tryptic peptide from AP2C contained amino acid KNMLLAAQQLCK, spanning amino acid
residues 349–360 with an expectation value of 0.0007.
Figure 6 Transcription characterization with 1-D WB.
TF characterization with one-dimensional Western blotting (1-D WB).
1D-SDS-PAGE gel was electro-blotted onto a PVDF membrane and then
probed with the following antibodies: TATA binding protein (TBP), RNA
Polymerase II (Pol II), upstream stimulatory factor 2 (USF2), specificity
protein 1 (SP1), and βactin. The individual lanes of the SDS-PAGE gel
were loaded with whole cell lysate (WCL, protein from the cytosol as
well as nucleus) obtained from sonication followed by centrifugation to
remove cell debris; nuclear extract (NE); hTERT promoter trapping eluent
(PTE). Bands indicate components that are specific to the hTERT
promoter as well as demonstrate purification of specific TF from the
complex mixtures of WCL and NE.
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complete hTERT promoter sequence.
To illustrate the reproducibility of PT, triplicate PT el-
uates were analyzed from the HEK-293 cell line by mass
spectrometry (Figure 9). Replicate experiments of each
cell line were compared with Scaffold version 3.6.2 and
identifications were accepted with a minimum of 99%
protein probability. For HEK293, 208 proteins were
found to be in all three purifications. These are shown
in Additional file 1: Table S1 as a hyperlinked Excel
spreadsheet where more information can be found. Most
are either known DNA- or RNA-binding proteins, in-
cluding known components of the TFII complex. Add-
itionally, TFs purified by PT from HeLa nuclear extract
had 86 proteins found in duplicate experiments. Since
the same amounts of proteins were analyzed using the
same analysis parameters, we conclude that the two cell
lines differ in the exact composition of their transcrip-
tion complex. A further comparison of the two cell lines
showed that the pooled HEK-293 results when com-
pared to the pooled HeLa results have 129 proteins in
common. Further investigation must be done to dissect
the significance of these findings. However, based on MS
data acquired for these two cell lines, over 100 proteins
are bound by the promoter in a transcriptionally active
complex.
To analyze the core of the transcriptional complex,
each promoter trap experiment was analyzed individu-
ally. Sixty proteins were found in each of the five
Figure 7 MS/MS fragmentation of RPELLTHSTTEVTQPR found
in GTF2-I_HUMAN. General transcription factor II-I (TFII-I) was
identified by LC/MSMS and was matched to 622.3338 m/z (3+) by
protein database searching with Mascot software utilizing the
SwissProt database. TFII-II was identified with a Mascot protein score of
77 and sequence coverage of 6%. The top-ranked tryptic peptide from
TFII-I contained amino acid RPELLTHSTTEVTQPR, spanning amino acid
residues 540–555 with an expectation value of 5.9 × 10−05.
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eliminates any protein not found in every sample, and
since AP-2 and Sp1 were missing from one or more of
the data sets, they are not included. Of this set, 52%
were found to be involved in transcriptional regulation.
The data also shows that 50% are involved in RNA pro-
cessing and 22% in DNA processing. 28% of the identi-
fied proteins are known to be involved in transcription.
The 60 proteins were then grouped according to their
cell line, to determine if there was a significant differ-
ence based on spectral counts, which could implicate
regulatory differences amongst different biological sets
(Figure 10). The protein numbers on the abscissa are those
from Additional file 2: Table S2. Asterisks displayed in the
graph correspond to a significant difference in spectralFigure 8 Electrophoretic Mobility Shift Assay (EMSA) of 32P-labeled DN
From left to right, radiolabeled SP1, AP-2 and E-Box specific oligonucleotid
(unlabeled) was added to show the specificity for hTERT promoter DNA ascounts (95% confidence interval calculated by ANOVA)
between HEK293 and HeLa; only twelve proteins were sig-
nificantly different in spectral counts although they are
present in all samples. It should also be noted that both
cell lines, HEK293 and HeLa, follow the same protein
abundance trend. This suggests that the core of the tran-
scriptional complex is not dependent on cell type.
In three replicate promoter trap samples using HEK293
we were able to identify transcription factor AP2 however,
two were identified as the delta and one identified as the
gamma isoforms. SP1 was identified in two of the three
samples with one being isoform B. Neither SP1 nor AP2
were identified in HeLa. The mascot scores and percent
coverage of AP2 and SP1 for HEK293 are given in Table 1.
From this data we can conclude that promoter specific
transcription factors are enriched using the PT tech-
nique and detectable through mass spectrometry be-
tween 67%-100% for HEK293 but unsuccessful for HeLa
cells. One is an embryonic cell (HEK293) while the other
is a cancer cell (HeLa) line and this may account for the
difference but clearly the method would need further
optimization when HeLa cells are analyzed for specific
transcription factors. When working with less active pro-
moters such as hTERT instead of the c-jun initially studied,
a different approach may be desirable. Success could pos-
sibly be increased by using a directed proteomics approach
or concentrating the promoter trap elute, assuming that
the problem is with a limit of detection and not a lack of
enrichment. Here we show that using Promoter Trapping
not only can general transcription factors be purified but
also promoter specific transcription factorsas well as the
ability to visualize the interaction of different transcription
factors on each other’s binding site.A containing specific DNA sites to study DNA-protein interactions.
es were incubated with promoter trap eluate. Competitor DNA
well as interactions.
Figure 9 Replicate experiments using PT from cell lines HEK293 and HeLa cell. Protein identification of PT elute was achieved with the use
of mass spectrometry and analyzed with Scaffold version 3.6.2, Proteome Software Inc. Any protein identified with greater than a 99% possibility
and two unique peptides with at least 95% probability were considered. Reproducibility of triplicate PT experiments with HEK293 cell line is
shown by the overlapping region of HEK293 PT 1, 2, and 3 with 208 proteins in common. HeLa cell line was also compared in duplicate and was
found to have 86 proteins which occur in both experiments. 60 proteins were found to be in common in all five of the experiments. These
proteins are specified in an Excel spreadsheet file in Additional file 2: Table S2.
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Cloning of hTERT-pUC19
50 μL PCR reactions contained 200 nM forward primer
(FP, ACGGGATCCCTCCCCACGTGGCGGCGGAGG)
and reverse primer (RP, CGGAATTCGGAGCGCGCG
CGCGGCATCGC), 30 μL 1:100 human heart genomic
DNA (399 ng total), 200 μM dNTP, 5 μL 10X ThermoPol
buffer (New England BioLabs, Ipswich, MA, USA) and 1 U
Taq DNA polymerase (New England Biolabs, Ipswich,Figure 10 Graphical representation of proteins identified in all sampl
key proteins that are present in all data sets. Sixty proteins were found in a
compared to each other based on cell line with HEK293 shown as black ba
Additional file 2: Table S2 while spectral counts are shown on the ordinate
specific proteins corresponds the analysis of variance. A significant differen
for 12 separate proteins.MA, USA). The bold primer sequences are unique BamHI
and EcoRI sites being added to promoter primer sequences.
The mixture was heated to 95° for 5 min and thermocyled
95°C for 1 minute, 60°C for 1 minute, and 72°C for 2 mi-
nutes for 35 cycles and finally held at 72°C for 10 minutes
for extension. The ~300 base pair product was then gel
purified and cloned by ligating EcoRI/BamHI digested frag-
ments into EcoRI/BamHI digested pUC19 vector. The
resulting plasmid (hTERT-pUC19) was confirmed to havee sets. Each promoter trap sample was treated individually to identify
ll of the promoter trap experiments. Resulting proteins were then
rs and HeLa is shown in grey. The protein numbers (abscissa) are from
. Error bars are calculated based on standard deviation. Asterisks above
ce based on 95% confidence interval calculated by ANOVA is shown
Table 1 Identification of hTERT promoter specific
transcription factors in HEK293 cell nuclear extract
Percent coverage Mascot score
Transcription Factor AP2 delta 4%, 4% 28, 33
Transcription Factor AP2 gamma 3% 25
SP1 Transcription Factor Isoform b 2% 25
Transcription Factor SP1 5% 33
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sequencing.
Synthesis of (GT)5 tailed hTERT promoter
The tailed hTERT was synthesized in two separate PCR
reaction; these differ only in the primers used:
Anti-sense reaction
PCR was performed as described above using 200 nM re-
verse primer (RP), 200 nM 5′ phosphorylated and (AC)5
version of forward primer (FPP, ACACACACACACGG
GATCCCTCCCCACGTGGCGGCGGAGG) and 100 ng
hTERT-pUC19 as template.
Sense reaction
As above except using 5′ phosphorylated and (AC)5 ver-
sion of reverse primer (RPP, ACACACACACCGGAAT
TCGGAGCGCGCGCGCGGCATCGC) and forward pri-
mer (FP). The results of the two reactions are a DNA
fragment in which one stand in each reaction is 5′
phosphorylated and has an (AC)5 tail, while the other
strand is not phosphorylated and has a 3′ (GT)5 tail.
The PCR reactions were purified using the PCR purifi-
cation kit from Qiagen. The sense reactions and anti-
sense reactions were pooled separately and 200 μL of
each pool mixed with 20 μL 10X λ exonuclease buffer
(New England Biolabs, Ipswich, MA, USA) and 20 U λ
exonuclease, and incubated at 37° for two hours. This
allowed only the phosphorylated 5′ end strand to be de-
graded. The resulting two single strands were gel puri-
fied. The sense and anti-sense strands were mixed 1:1
and annealed at 95°C for five minutes and then cooled
to room temperature over the course of an hour. To en-
sure the duplex promoter was formed the digested sense,
anti-sense, and annealed DNA were run on a 2% agarose
gel. Once the annealed product was confirmed the DNA
was concentrated using a 3 kDa MWCO centrifuge filter
(Millipore, Billerica, MA, USA) at 4°C. OD260 was taken
to calculate the concentration using the following
equation:
OD260 nmð Þ  dilution factorð Þ  50 μg=ml
¼ DNA μg=mlð ÞPreparation of HEK293 nuclear extract
HEK 293 cells were cultured and nuclear extract was pre-
pared as described previously by S. Jiang, M.R. Galindo,
H.W. Jarrett, Proteomics 10 (2010) 203. HeLa cell were cul-
tured and nuclear extract prepared by the same procedure.
Preparation of (AC)5-Sepharose
(CA)5-Sepharose was prepared as described [9].
Promoter trapping
All operations were performed at 4°. HEK293 nuclear
extract (500 μg) and 10 nM duplexed DNA (hTERT pro-
moter), containing a single stranded (GT)5 tail on the 3′
ends, were combined in 100 μL 5X binding buffer (BB:
50 mM NaCl, 10 mM HEPES, 10 mM MgCl2, 1 mM
EDTA, 50 μM ZnSO4, 1 mM DTT, pH 7.5 and 30 μg/
mL poly dI:dC (Sigma, St. Louis, MO, USA)), in a final
volume of 500 μL. The reaction mixture was incubated
at room temperature for 30 minutes. The complex is
purified by annealing the (GT)5 tailed promoter complex
to a 1 mL (CA)5-Sepharose column. The column is
washed with 20 column volumes of binding buffer and
then the promoter specific transcription factors are
eluted with 5 column volumes of TE0.5 (10 mM Tris,
pH 7.5, 1 mM EDTA, 0.5 M NaCl). The eluate was con-
centrated using an Amicon Ultra-0.5 mL 10 kDa mo-
lecular weight cut off centrifuge filter and desalted by
buffer exchange with 50 mM ammonium bicarbonate.
Electrophoresis
Nuclear extract (NE) and promoter-trapped proteins
were further fractionated by electrophoresis. Samples
were resolved on one dimensional 12% SDS-PAGE
(1DE) by the method of Laemmli [14]. In other experi-
ments, two-dimensional electrophoresis (2DGE) was
performed with the first dimension being isoelectric fo-
cusing, performed on a 7 cm, pH 3–10 IPG strip, and
the second dimension further resolves the proteins by
their relative molecular mass with the use of a 12% so-
dium dodecylsulphate-polyacrylamide gel electrophoresis
(SDS-PAGE). The resulting SDS-PAGE gel was silver
stained to visualize the location of the proteins or
characterization of the individual proteins was accom-
plished with a variety of methods to include mass spec-
trometry, Southwestern blots, and Western blots.
Enzymatic digestion
In-Gel digestion
2DGE gels were cut into 1 mm square blocks. Each gel
slice was cut into small pieces and placed into tubes.
200 μL of 100% acetonitrile (ACN) was added to each
tube and the gel was allowed to shrink for 10 minutes
(acrylamide turns opaque). The supernatant was re-
moved and discarded. 10 mM dithiothreitol (DTT) in
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they are completely submerged (~200 μL) and incubated
at 37° for one hour and then 500 μL of ACN was added
and left for 10 minutes. The supernate was removed and
discard. Then 200 μL of 55 mM iodoacetamide in 50 mM
NH4HCO3 was added and the pieces completely sub-
merged and incubated for one hour at 37° in the dark.
500 μL of 100% ACN was next added for 10 minutes. If
gel pieces are not opaque, the supernatant is removed and
100% ACN is again added for dehydration. The supernate
is again removed and discarded. An excess of trypsin solu-
tion (~200 μL, 100 ng/μL of Trypsin Gold, Promega,
Madison, WI, USA in 50 mM NH4HCO3) is added to
completely cover gel pieces, allowed to re-hydrate with
trypsin on ice or at 4° for 60 min. and then incubated at
37° overnight. To extract the peptides, the tubes are then
centrifuged and the supernatant is placed in a fresh tube.
0.1% TFA, 50% ACN was added to the gel pieces and in-
cubated for 15 minutes. The supernatant was then
removed and combined with the previous extract. The
samples were then dried (SpeedVac) and dissolved in
10 μL 0.1% triflouroacetic acid (TFA).Promoter trapping eluate digestion
Urea was added to 100 μL of concentrated promoter trap
eluate to a final concentration of 8 M and incubated at 37°
for one hour in order to denature the proteins. The sam-
ple was made 10 mM DTT by the addition of 500 mM
DTT and incubated at 37° for one hour. The protein was
alkylated by adding of 400 mM iodoacetamide to the solu-
tion to make a final concentration of 40 mM iodoaceta-
mide and incubation at 37° for one hour in the dark. The
sample was then diluted 10-fold with 50 mM NH4HCO3
and 1 μg/μL Trypsin in 50 mM NH4HCO3 was added to
give a final ratio of 1:50 trypsin: protein (w/w). The solu-
tion is incubated overnight at 37°. TFA was added to make
final concentration 0.1% TFA and the sample applied to a
C18 Spin Columns (Pierce, Rockford, IL, USA) and eluted
with 0.1% TFA, 70% ACN. Eluate from the C18 Spin Col-
umn was further concentrated in a SpeedVac to dryness
and then re-suspended in 10 μL 0.1% TFA.
Characterization
Mass spectrometry
The resulting peptides were analyzed by capillary LC/MS/
MS by injecting 2 μl onto a 50 μm-i.d. column packed to
7 cm of 3 μm C-18 silica and an integrated nano-
electrospray emitter with a flow rate of 350 nL/min with a
reverse phase gradient of 2 to 62% of 0.1% formic acid in
ACN over 60 minutes. Fragmentations of the ten most
abundant peptides were carried out with a hybrid linear
ion trap-Fourier-transform tandem mass spectrometer
(LTQ-Elite, ThermoFisher, San Jose, CA, USA) via high-energy C-trap dissociation in positive ion mode. Multiple
charged peptide precursor ions were fragmented to give
spectra for the complementary N- and C-terminal
sequence-specific product ions.Protein database searching
Database searching was carried out using a 10-node Mas-
cot cluster (version 2.3.02, Matrix Science, London, UK)
using the Swiss-Prot database (release 2012_11; 538,577
sequences). Search criteria included peak picking with
Mascot Distiller, 10 ppm precursor ion mass tolerance,
0.8 Da product ion mass tolerance, three missed cleavages,
enzymatic digestion by trypsin, and oxidation of methio-
nine and iodoacetamide derivatives of cysteine were speci-
fied as variable modifications. Replicate experiments were
compared and analyzed with Scaffold version 3.6.2 (Prote-
ome Software Inc., Portland, OR).Western blot
Protein collected from Promoter Trapping of 500 μg nu-
clear extract was further resolved by 12% SDS-PAGE and
electro-blotted onto a polyvinylidene fluoride (PVDF)
membrane. The membrane was then blocked with 5%
milk, 3% BSA in Tris buffered saline (TBS) for one hour at
room temperature. The membrane was probed separately
with primary antibodies. The antibodies used were TBP,
Pol-II, USF-2, SP1, and β-actin from rabbit (Santa Cruz
Biotechnology, Inc., Dallas, TX, USA). Each antibody was
used in a 1:100 dilution in 5% BSA in TBS. The membrane
was allowed to incubate with the primary antibody over-
night at 4°C. The following day the membrane was washed
once with TBS and then probed with the secondary anti-
body (goat anti rabbit-horse radish peroxidase, Santa
Cruz Biotechnology, Inc., Dallas, TX, USA) at 1:5000 in
5% milk. Detection was accomplished with enhanced
luminol-based chemiluminescent substrate (Immuno-
Cruz, Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA) and instructions provided by the manufacturer.Southwestern blot
Following the method of [15], the PT elute was separated
by 2DGE and then electro-blotted onto a PVDF mem-
brane. Proteins were renatured and the membrane
blocked [15]. The next day the membrane was washed
four times with Southwestern blot buffer (SWBB: 10 mM
HEPES/NaOH, pH 7.9, 50 mM NaCl, 10 mM MgCl2,
0.1 mM EDTA, 1 mM DTT, 50 μM ZnSO4, and 0.1%
Tween) and then incubated with 2 nM radiolabeled
hTERT promoter DNA probe in SWBB containing 10 μg/
mL poly dI:dC and 0.25% BSA. The next day the mem-
brane was washed with SWBB and exposed to film for
12 hours for autoradiography.
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EMSA was performed using 32P labeled oligonucleotide
probe containing specific oligonucleotides sequences for
SP1, AP-2 and E-Box (purchased commercially). DNA-
protein complexes were resolved on a non-denaturing
5% polyacrylamide gel and visualization by autoradiog-
raphy as previously described [16]. Competition assay
was accomplished by addition of 40-fold molar excess of
unlabeled competitor DNA, SP1, AP-2, E-Box, or
hTERT, to the Promoter Trap elute prior to adding radi-
olabeled oligonucleotide.Transfection and luciferase reporter assay
The hTERT promoter DNA was subcloned from pUC19
to pMLUC luciferase vector (Novagen, San Diego, CA,
USA) between the BamHI and EcoRI restriction sites.
HEK293 cells were plated onto a 12-well plate with
90,000 cells (500 μL) and allowed to incubate at 37°
for 24 hours in DMEM medium supplemented with
10% fetal bovine serum resulting in 60% confluence. In
two separate microfuge tubes the following were
combined to make a 100 μL transfection media and
allowed to incubate at room temperature for 15 minutes:
90 μL serum free medium, 2 μg pTK-Luciferase normalizat-
ion reporter DNA, 5 μL GeneJuice® (EMD Millipore,
Billerica, MA) and 0.023 μg of either empty vector con-
trol or hTERT-pLUC. After incubation, the medium is
removed from the plates and replaced with 500 μL of
10% serum media. 20 μL of the different transfection
media was added to separate wells in triplicate and the
plate was incubated at 37° overnight. The next day, the
media is replaced and incubate at 37° for an additional
24 hours. The cells are then harvested and assayed for
firefly and Renilla luciferase with the reagents and pro-
cedure provided by Dual Luciferase Reporter Assay
System (Promega, Madison, WI). Briefly, the media is
removed and the cells washed with phosphate buffered
saline. 100 μL of passive lysis buffer was added and
rocked at room temperature for 30 minutes. 30 μL of
the cell lysate was added to 20 μL LARII and placed in a
luminometer to take an initial reading. Then, 50 μL of
Stop and Glo® Reagent was added and a second reading
was taken. The Renilla luciferase activity (hTERT) was
divided by the Firefly luciferase activity (TK) to give
relative luciferase activity.
Transcription assay
Transcription was measured by a primer extension
method. PT elute obtained from 200 μg nuclear extract
was diluted to a final volume of 200 μL in TE0.1 buffer
in the presence of 10 nM untailed hTERT promoter
DNA (final concentration), 600 μM rNTP, 25 unitsRNasin, 2.5 mM DTT, 3U creatine phosphate kinase,
and 12 mM phosphocreatine and incubated for 60 mi-
nutes at 30°. The produced RNA was extracted with
phenol/chloroform and precipitated with ethanol. For
primer extension, the RNA was dissolved in 10 μL an-
nealing buffer (5 mM Tris–HCl, pH 8.3, 1 mM EDTA,
and 75 mM KCl) containing 0.1 pmol 32P labeled oligo-
nucleotide primer (5′-cggagcgcgcggcatcgcgg-3′) and
annealed at 50° for 45 minutes. Primer extension was
achieved by adding 20 μL annealing buffer to produce a
final solution concentration of 15 mM DTT, 4.5 mM
MgCl2, 0.5 mM dNTP, 1.5 μg actinomycin D, 25 units
RNasin, and 200 U Moloney Murine Leukemia Virus re-
verse transcriptase to make a final volume of 30 μL and
incubated at 37° for 60 minutes. The product was sepa-
rated with 8 M urea in a 6% polyacrylamide gel and visu-
alized by autoradiography. As a negative control the
experiment was repeated without the addition of rNTP
or without the addition of hTERT promoter DNA to en-
sure any visualized bands were not artifacts.
Additional files
Additional file 1: hTERT Promoter Trap Protein Identifications in
Cell Line HEK293. A list comprised of all 208 proteins, with hyperlinks,
identified in all three replicate PT experiments. Proteins were chosen
based on a minimum of 99% protein probability using Scaffold version
3.6.2.
Additional file 2: Common Proteins Identified in Cell Lines HEK293
and HeLa using the hTERT Promoter. A chart comprised of 60 proteins
that were identified in both HEK293 and HeLa cell lines. Proteins were
chosen based on a minimum of 99% protein probability using Scaffold
version 3.6.2. A significant difference in spectral counts, based on a 95%
confidence interval calculated by ANOVA, was denoted by an asterisk.
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